Results 1 to 10 of about 23,268 (163)

Mantle cell lymphoma

Haematologica, 2009
This perspective article by Drs. Pileri and Falini examines the diagnosis and bio-pathology of mantle cell lymphoma in the light of the criteria of the WHO Classification and recent reports. See related articles on pages 1555, 1563 and 1595.
Stefano A. Pileri, Brunangelo Falini
doaj   +3 more sources

Indolent mantle cell lymphoma

Haematologica, 2011
Mantle cell lymphoma (MCL) accounts for approximately 6% of all non-Hodgkin’s lymphomas[1][1] and is characterized by the over-expression of cyclin D1 with cell cycle dysregulation, secondary to the genetic abnormality t(11;14)(q13;q32).[2][2] It often has an aggressive clinical course and ...
Michelle Furtado, Simon Rule
doaj   +3 more sources

Smoldering mantle cell lymphoma [PDF]

Journal of Experimental & Clinical Cancer Research, 2017
Background Mantle cell lymphoma (MCL) is an aggressive disease, with poor prognosis and a limited survival. However, some patients with indolent MCL can survive beyond 7~10 years. These patients remain largely asymptomatic and can be in observation for a
Haige Ye, Aakash Desai, Dongfeng Zeng, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed, Michael L. Wang   +6 more
doaj   +3 more sources

Mantle cell lymphoma

Blood Reviews, 1994
The term mantle cell lymphoma (MCL) has been introduced recently, to describe lymphomas related to the primary B follicle and the mantle of the secondary lymphoid follicle. MCL forms a subset of diffuse small cleaved cell lymphomas according to the Working Formulation and correspond closely to the centrocytic lymphomas described in the Kiel ...
C, De Wolf-Peeters, S, Pittaluga
openaire   +4 more sources

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma

Pathology and Oncology Research, 2023
Composite mantle cell lymphoma and classical Hodgkin lymphoma is very rare and the actual origin of it is still unclear. Here we reported a new case of composite mantle cell lymphoma and classical Hodgkin lymphoma and analyzed its molecular changes ...
Hongyu Wang, Liqun Yang, Qiuyao Li, Haiyun Song, Hong Ji   +4 more
doaj   +1 more source

Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission ☆

Hematology/Oncology and Stem Cell Therapy, 2023
Mantle cell lymphoma is a rare subtype of non-Hodgkin’s lymphoma with poor prognosis and continue to be challenging to treat. The choice of first line induction regimen remains a topic of debate due paucity of clinical trials.
Omar Albanyan, Samer Alkassis, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, Abhinav Deol   +9 more
doaj   +1 more source

Bilateral vision loss as the initial presentation for central nervous system involvement of mantle cell lymphoma: A case series

American Journal of Ophthalmology Case Reports, 2021
Purpose: Mantle cell lymphoma is a rare aggressive subtype of non-Hodgkins B cell lymphoma. It typically presents with asymptomatic monoclonal lymphocytosis, lymphadenopathy or bulky extranodal disease.
L. Small, C. Ma, M. Shah, S. Ramanathan, N. Rasool   +4 more
doaj   +1 more source

Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways

Haematologica, 2012
Background There is increasing evidence that stromal cell interactions are required for the survival and drug resistance of several types of B-cell malignancies.
Daniel J. Medina, Lauri Goodell, John Glod, Céline Gélinas, Arnold B. Rabson, Roger K. Strair   +5 more
doaj   +1 more source

Mantle cell lymphoma presenting with severe upper gastrointestinal bleeding

Medicine, 2022
. Introduction:. Although it usually involves extranodal sites such as the gastrointestinal tract in more than 80% of cases, mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially severe and life-threatening bleeding ...
Khaled Ali, MD, Mhd Baraa Habib, MD, Ferial Alloush, MBBS, Mohamed A. Yassin, MBBS, CABM, MSC, FACP, MSC   +3 more
doaj   +1 more source

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

Haematologica, 2009
Background Cyclin D1-negative mantle cell lymphoma is difficult to distinguish from other small B-cell lymphomas. The clinical and pathological characteristics of patients with this form of lymphoma have not been well defined.
Ana Mozos, Cristina Royo, Elena Hartmann, Daphne De Jong, Cristina Baró, Alexandra Valera, Kai Fu, Dennis D. Weisenburger, Jan Delabie, Shih-Sung Chuang, Elaine S. Jaffe, Carmen Ruiz-Marcellan, Sandeep Dave, Lisa Rimsza, Rita Braziel, Randy D. Gascoyne, Francisco Solé, Armando López-Guillermo, Dolors Colomer, Louis M. Staudt, Andreas Rosenwald, German Ott, Pedro Jares, Elias Campo   +23 more
doaj   +1 more source